UCB SA (FRA:UNC) Stock News, Headlines & Updates
UCB SA Stock News from GuruFocus
- 1
Jun 13, 2024
New CIMZIA® data for women living with chronic rheumatic diseases throughout pregnancy, and for people living with RA and high rheumatoid factor levels
PRNewswire • 7:00am
Jun 12, 2024
UCB to share first presentations of BIMZELX® (bimekizumab-bkzx) two-year data in axial spondyloarthritis and psoriatic arthritis at EULAR 2024
PRNewswire • 7:00am
May 23, 2024
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in Moderate-to-Severe Hidradenitis Suppurativa
PRNewswire • 7:00am
Apr 25, 2024
UCB SA's Dividend Analysis
GuruFocus Research • 5:04am
Apr 10, 2024
UCB Launches Make HStory, an Educational Campaign Offering Resources and Support for Those Living with Hidradenitis Suppurativa
PRNewswire • 8:00am
Apr 04, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news